Siemens Healthcare Diagnostics, Inc. Dimension IBCT Flex Reagent Cartridge. The total (IBCT) method used on the Dimension system is an in vitro diagnostic test intended to quantitatively measure Total Iron Binding capacity in human serum and plasma. Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Dimension IBCT Flex Reagent Cartridge. The total (IBCT) method used on the Dimension system is an in vitro diagnostic test intended to quantitatively measure Total Iron Binding capacity in human serum and plasma.
Brand
Siemens Healthcare Diagnostics, Inc.
Lot Codes / Batch Numbers
Catalog number df84
Products Sold
Catalog number df84
Siemens Healthcare Diagnostics, Inc. is recalling Dimension IBCT Flex Reagent Cartridge. The total (IBCT) method used on the Dimension system is an in due to Test produces falsely elevated IBCT results and Abnormal Reaction test report messages on heparinized plasma samples.. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Test produces falsely elevated IBCT results and Abnormal Reaction test report messages on heparinized plasma samples.
Recommended Action
Per FDA guidance
Siemens issued an "Urgent Field Safety Notice" letter dated December 2009 to users identifying the issue and affected product. Customers were instructed not to use heparinized plasma samples for IBCT testing. IBCT Instructions for Use (IFU) has been updated to reflect that heparinized plasma is no longer an acceptable sample type. Beginning with lot ED0341, the new IFU will be packaged in the carton with the IBCT Flex reagent cartridges. Consignees were requested to forward the notification letter to anyone to whom the product was distributed. The Siemens Technical Solutions Center can be contacted at 800-441-9250.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026